Julien de Jager
Julien de Jager publishes mostly in Rheumatology, Nephrology and Hematology, on topics such as Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Autoimmune and Inflammatory Disorders Research.
- World rank
- #4,072,654 of 7,710,434 ranked researchers
- Rank in Australia
- #101,838 of 140,210
- Works
- 19
- Citations
- 334
- Citations per work
- 17.6
What does Julien de Jager research?
Julien de Jager's work is mostly in Medicine (67%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1367.4%
- Medicine1367.4%
- Everything else632.6%
- 1Rheumatology36% of their works
- 2Nephrology7% of their works
- 3Hematology7% of their works
- 4Epidemiology7% of their works
- 5Genetics6% of their works
- 6Hepatology4% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Autoimmune and Inflammatory Disorders Research
- Gout, Hyperuricemia, Uric Acid
- Inflammatory Myopathies and Dermatomyositis
- Chronic Lymphocytic Leukemia Research
- Systemic Lupus Erythematosus Research
- Psoriasis: Treatment and Pathogenesis
Which keywords describe Julien de Jager's research?
The keywords of their largest research topics: Autoantibodies, Cardiovascular Risk, Inflammation, Biological Therapy, Rheumatoid Arthritis, Ankylosing Spondylitis, Spondyloarthritis and Hemophagocytic Lymphohistiocytosis.
- IL-17
- Inflammatory Myopathies
- Dermatomyositis
- Antiphospholipid Syndrome
- Juvenile Idiopathic Arthritis
- Hemophagocytic Lymphohistiocytosis
- Ankylosing Spondylitis
- Biological Therapy
- Cardiovascular Risk
- Autoantibodies
- Inflammation
- Rheumatoid Arthritis
- Spondyloarthritis
- Hyperuricemia
- Uric Acid
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- Systemic Lupus Erythematosus
- TH17 Cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Autoantibodies183 topics
- Cardiovascular Risk162 topics
- Inflammation162 topics
- Biological Therapy121 topic
- Rheumatoid Arthritis121 topic
- Ankylosing Spondylitis51 topic
- Spondyloarthritis51 topic
- Hemophagocytic Lymphohistiocytosis41 topic
- Hyperuricemia41 topic
- Juvenile Idiopathic Arthritis41 topic
- Uric Acid41 topic
- Antiphospholipid Syndrome31 topic
- Chronic Lymphocytic Leukemia31 topic
- Dermatomyositis31 topic
- Genomic Aberrations31 topic
- Inflammatory Myopathies31 topic
- Systemic Lupus Erythematosus31 topic
- IL-1721 topic
- TH17 Cells21 topic
Where does Julien de Jager work?
Julien de Jager's main affiliation in the publication record is Barwon Health, Australia.
How many publications and citations does Julien de Jager have?
OpenAlex counts 19 works and 334 citations for Julien de Jager, an h-index of 10, ranking #4,072,654 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Julien de Jager. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.